Financial Performance - The company's revenue for Q3 2021 was ¥171,609,104.93, a decrease of 16.34% compared to the same period last year[3]. - Net profit attributable to shareholders was ¥22,121,912.27, down 28.41% year-on-year, while the net profit excluding non-recurring gains and losses was ¥21,275,078.22, a decrease of 33.64%[3]. - Total operating revenue for Q3 2021 reached ¥572,884,248.33, an increase from ¥444,395,559.52 in the previous period[23]. - Operating profit for the period was ¥120,971,502.78, compared to ¥54,312,182.04 in the same period last year, reflecting a significant growth[24]. - Net profit for Q3 2021 was ¥121,021,881.50, up from ¥46,897,099.26 in the previous year, indicating a year-over-year increase of approximately 158%[24]. - Total comprehensive income for the period reached CNY 121,021,881.50, compared to CNY 46,897,099.26 in the previous period, indicating a significant increase[25]. - Basic and diluted earnings per share were both CNY 0.99, up from CNY 0.38 in the same period last year, reflecting strong profitability growth[25]. Assets and Liabilities - The total assets at the end of the reporting period were ¥909,953,766.03, reflecting a 3.50% increase from the end of the previous year[3]. - Total assets amounted to ¥909,953,766.03, an increase from ¥879,177,170.27 at the end of the previous period[22]. - Total liabilities decreased to ¥164,584,464.47 from ¥223,715,822.15, indicating improved financial stability[21]. - Current liabilities reached ¥220.92 million, with accounts payable at ¥70.17 million and short-term borrowings at ¥39.05 million[31]. - Total liabilities were reported at ¥223.72 million, with non-current liabilities accounting for ¥2.80 million[32]. - Owner's equity totaled ¥655.46 million, with retained earnings of ¥190.83 million and capital reserves of ¥323.23 million[32]. Cash Flow - Cash flow from operating activities showed a net outflow of ¥3,494,620.54, a decline of 104.56% compared to the same period last year[9]. - Cash inflows from operating activities totaled CNY 603,783,936.54, compared to CNY 504,359,298.12 in the previous period, representing an increase of approximately 19.7%[26]. - The net cash flow from operating activities was negative at CNY -3,494,620.54, a decline from CNY 76,662,629.14 in the prior year, indicating operational challenges[28]. - Cash inflows from investment activities amounted to CNY 374,835,397.52, compared to CNY 346,226,953.20 in the previous period, showing a growth of about 8.3%[28]. - The net cash flow from investment activities was CNY 54,273,560.50, a significant improvement from CNY -364,957,564.85 in the same period last year[28]. - Cash and cash equivalents at the end of the period were CNY 175,823,317.82, down from CNY 198,712,001.88 at the beginning of the period[28]. - Total cash outflows from operating activities were CNY 607,278,557.08, compared to CNY 427,696,668.98 in the previous period, indicating increased operational expenses[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 4,421[12]. - The largest shareholder, Chen Qinfang, holds 37.00% of the shares, amounting to 45,193,500 shares[12]. - Liu Xiaowei, the second-largest shareholder, holds 12.33% of the shares, totaling 15,064,500 shares[12]. Research and Development - The company reported a significant increase in research and development expenses, which rose by 256.54% to ¥69,316,626.75 due to new subsidiary investments[8]. - Research and development expenses surged to ¥69,316,626.75, compared to ¥19,441,357.35 in the prior period, highlighting a focus on innovation[23]. Corporate Governance - The company is in the process of electing new board members, with nominations for both non-independent and independent directors[13]. - The third board of supervisors will include representatives elected from the employee representative assembly[14]. - The company has completed the registration change for its legal representative following the election of the new board chairman[17]. - The company is actively engaging in corporate governance changes, including the appointment of senior management[16]. - The company has disclosed its governance changes through various financial news platforms[15]. Other Financial Metrics - The company has a cash balance of 175,823,317.82 yuan as of September 30, 2021, down from 198,712,001.88 yuan at the end of 2020[19]. - Trading financial assets decreased from 114,874,489.58 yuan at the end of 2020 to 50,376,157.05 yuan by September 30, 2021[19]. - The company has adopted new leasing standards starting from 2021, which may impact future financial reporting and asset valuations[29]. - The report indicates a significant increase in intangible assets, totaling ¥14.89 million[31]. - Deferred tax assets were recorded at ¥9.39 million, contributing to the overall asset structure[31]. - The company has a lease liability of ¥12.17 million, reflecting its commitments under new leasing standards[32]. - The report highlights a total of ¥47.38 million in contract liabilities, indicating future revenue obligations[31]. - The company has not disclosed any new product developments or market expansion strategies in this report[33].

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 401,275,143.40, representing a 67.71% increase compared to CNY 239,272,558.62 in the same period last year[19]. - The net profit attributable to shareholders of the listed company reached CNY 98,899,969.23, a significant increase of 518.30% from CNY 15,995,341.49 in the previous year[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 97,580,250.47, up 786.51% from CNY 11,007,183.10 year-on-year[19]. - The basic earnings per share increased to CNY 0.81, reflecting a 523.08% rise from CNY 0.13 in the same period last year[19]. - The total operating revenue for the reporting period reached CNY 401,275,143.40, representing a year-on-year increase of 67.71% compared to CNY 239,272,558.62 in the same period last year[38]. - The total comprehensive income for the first half of 2021 was CNY 3,536,036.07, compared to CNY 10,071,957.34 in the same period of 2020[130]. - The company reported a significant increase in prepayments, which rose to CNY 91,782,872.59 from CNY 11,930,172.34, indicating a growth of 669.5%[115]. - The company reported a profit distribution of 4.614 million yuan to shareholders, indicating a focus on returning value to investors[140]. Assets and Liabilities - The total assets of the company at the end of the reporting period were CNY 915,214,466.76, a 4.10% increase from CNY 879,177,170.27 at the end of the previous year[19]. - The total assets at the end of the reporting period were 723.21 million yuan, showing stability in the company's financial position[140]. - The total liabilities decreased to CNY 191,997,764.39, a reduction of 14.2% from CNY 223,715,822.15[117]. - The total liabilities decreased to CNY 119,095,856.77 from CNY 164,715,604.74, indicating a reduction of approximately 27.6%[123]. - The cash and cash equivalents decreased to CNY 115,716,602.28, down from CNY 198,712,001.88, reflecting a decrease of 9.96% in total assets[41]. - The company's total cash inflow from investment activities was CNY 232,753,369.84, compared to CNY 112,280,779.20 in the first half of 2020, reflecting a growth of about 107.5%[134]. Cash Flow - The company reported a net cash flow from operating activities of CNY -31,100,027.12, a decrease of 287.07% compared to CNY 16,624,704.96 in the same period last year[19]. - The net cash flow from operating activities was negative at CNY -31,100,027.12, a decline from a positive CNY 16,624,704.96 in the previous year[133]. - The net cash flow from investment activities improved by 89.30%, reaching CNY -18,233,477.95 compared to CNY -170,390,300.85 in the previous period[37]. - The company reported a net cash outflow from financing activities of CNY -33,661,894.53, compared to CNY -12,217,879.51 in the previous year[134]. Business Strategy and Operations - The company plans to focus on the health care products sector, including personal care items and gaming business, following its acquisition strategy initiated in August 2020[27]. - The company emphasizes innovation and quality in its product offerings, aiming to provide safe and healthy consumer experiences[27]. - The company operates approximately 40,000 retail outlets across the country, with a focus on expanding into first and second-tier cities[33]. - The company has developed a robust R&D system with 1,002 proprietary trademarks, 44 invention patents, and 87 design patents[34]. - The company is focused on integrating online and offline brand communication resources to enhance brand awareness and drive revenue growth[54]. - The company plans to optimize its marketing channels and implement a comprehensive online and offline channel strategy to enhance sales performance[53]. Subsidiaries and Acquisitions - The company acquired 100% equity of Hainan Huaduo Network Technology Co., Ltd. and Hangzhou Lei Yan Network Technology Co., Ltd. in August 2020, which contributed to the change in profit sources[39]. - The revenue from the software and information technology services sector was CNY 140,599,060.28, accounting for 35.04% of total revenue, marking a 100% increase as it was a new addition[39]. - The company established new subsidiaries, Guangzhou Lei Yan Network Technology Co., Ltd. and Hainan Anchor Network Technology Co., Ltd., which reported net losses of CNY 1.52 million and CNY 0.04 million respectively[51]. Risks and Challenges - The company faces risks related to brand image infringement and intends to strengthen its brand protection measures through dedicated personnel and legal actions[52]. - The company is aware of the competitive risks in the gaming industry and is committed to developing new games to retain users and maintain market position[55]. Governance and Compliance - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board[150]. - The financial report was approved by the board of directors on August 30, 2021[150]. - The company and its subsidiaries are not classified as key pollutant discharge units by environmental protection authorities[65]. - There were no major related party transactions or significant contracts during the reporting period[78][84]. Research and Development - Research and development expenses surged to CNY 45,890,072.95, a significant increase of 433.55% from CNY 8,600,947.42, primarily due to the addition of new subsidiaries[37]. - The gaming segment has successfully launched popular titles such as "Kingdom of Heroes" and "Hundred Dragon Domination," showcasing strong development capabilities[34]. Shareholder Information - The major shareholder, Chen Qinfang, holds 37.00% of the shares, with a reduction of 15,064,500 shares during the reporting period[101]. - Liu Xiaowei, the second-largest shareholder, holds 12.33% of the shares, totaling 15,064,500 shares[101]. - The total number of shares held by the top 10 shareholders at the end of the reporting period is 69,394,500 shares[104]. - The total number of shares increased from 122,135,745 to 122,135,745, with limited sale condition shares rising from 53,738,375 to 54,278,125[95].

Financial Performance - The company's revenue for Q1 2021 was ¥216,717,972.68, representing a 135.55% increase compared to ¥92,005,273.17 in the same period last year[7] - Net profit attributable to shareholders reached ¥62,676,044.09, a significant increase of 937.66% from ¥6,040,118.93 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥61,816,134.13, up 1,648.06% from ¥3,536,279.25 in the previous year[7] - Basic earnings per share rose to ¥0.51, reflecting a 920.00% increase compared to ¥0.05 in the same period last year[7] - The weighted average return on equity improved to 9.13%, up 8.07 percentage points from 1.06% year-on-year[7] - The company's operating revenue for Q1 2021 reached CNY 216,717,972.68, a 135.55% increase compared to CNY 92,005,273.17 in Q1 2020, primarily due to the consolidation of two new subsidiaries and growth in the daily chemical sector[15] - The company reported a significant increase in R&D expenses, which rose by 551.76% to CNY 22,359,923.96 in Q1 2021, driven by the consolidation of two new subsidiaries[15] - The company reported a basic and diluted earnings per share of ¥0.51, up from ¥0.05 in the previous year[43] - The company achieved an operating profit of ¥63,385,335.93, a significant increase from ¥7,068,981.61 in the previous period[42] - The total profit for the current period was ¥63,421,855.30, compared to ¥7,064,988.42 in the previous period[42] Cash Flow and Investments - The net cash flow from operating activities was -¥33,167,525.98, an improvement of 31.75% compared to -¥48,653,019.41 in the same period last year[7] - Operating cash inflow for the current period was CNY 196,712,464.26, compared to CNY 90,673,649.44 in the previous period, representing an increase of approximately 117%[50] - Cash outflow from operating activities totaled CNY 229,879,990.24, up from CNY 139,326,668.85, indicating a rise of about 65%[50] - Cash inflow from investment activities was CNY 100,117,309.79, significantly higher than CNY 1,148,683.31 in the previous period[50] - Cash outflow from investment activities was CNY 117,421,980.20, down from CNY 160,800,715.58, showing a decrease of approximately 27%[50] - Net cash flow from investment activities was negative CNY 17,304,670.41, an improvement from negative CNY 159,652,032.27 in the prior period[50] - Cash and cash equivalents at the end of the period stood at CNY 147,257,380.50, compared to CNY 113,187,160.14 at the end of the previous period, reflecting an increase of about 30%[51] - The company reported a cash inflow of CNY 60,000,000.00 from investment recovery during the current period[52] Assets and Liabilities - Total assets at the end of the reporting period were ¥917,974,155.75, a 4.41% increase from ¥879,177,170.27 at the end of the previous year[7] - Net assets attributable to shareholders increased by 9.43% to ¥717,279,575.95 from ¥655,461,348.12 at the end of the previous year[7] - Total liabilities decreased to CNY 200,694,579.80 from CNY 223,715,822.15, a reduction of approximately 10.3%[34] - The company reported a significant reduction in short-term liabilities, totaling CNY 187,388,115.00, down from CNY 220,916,338.72, a decrease of approximately 15.2%[34] - The company's total equity increased to CNY 717,279,575.95 from CNY 655,461,348.12, reflecting a growth of approximately 9.4%[35] - The company’s retained earnings increased to CNY 252,650,781.89 from CNY 190,832,554.06, a rise of approximately 32.4%[35] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,806[11] - The company has cumulatively used CNY 11,219,700.00 of the raised funds as of March 31, 2021, with CNY 10,227,120.00 remaining in a dedicated account for future project investments[22] Regulatory and Management Practices - The company has implemented strict management protocols for raised funds, ensuring they are stored in dedicated accounts and used according to regulatory agreements[22] - The company has not engaged in any securities or derivative investments during the reporting period[18][19] - The first quarter report was not audited, which may affect the reliability of the financial data presented[62]

Financial Performance - The company's operating revenue for 2020 was CNY 680,571,308.29, representing a 31.52% increase compared to CNY 517,463,183.51 in 2019[16]. - The net profit attributable to shareholders for 2020 was CNY 102,240,267.90, a significant increase of 343.04% from CNY 23,076,746.81 in 2019[16]. - The net profit after deducting non-recurring gains and losses was CNY 91,722,575.51, which is a 475.07% increase from CNY 15,949,788.74 in 2019[16]. - The net cash flow from operating activities reached CNY 170,972,764.94, up 329.09% from CNY 39,845,342.00 in 2019[16]. - Basic earnings per share for 2020 were CNY 0.84, reflecting a 342.11% increase from CNY 0.19 in 2019[16]. - Total assets at the end of 2020 amounted to CNY 879,177,170.27, a 25.68% increase from CNY 699,552,468.03 at the end of 2019[16]. - The net assets attributable to shareholders were CNY 655,461,348.12, which is a 15.92% increase from CNY 565,434,654.72 in 2019[17]. - The weighted average return on equity for 2020 was 16.78%, up from 4.14% in 2019, indicating improved profitability[16]. Market and Product Development - The company engaged in mergers and acquisitions to enter the gaming industry, focusing on creative planning, development, and commercialization of online games[25]. - The company’s main products in the health care sector include shampoos, conditioners, and skincare products, with a focus on high-quality consumer experiences[26]. - The company has established strong brand recognition, with "Tihua Zhi Xiu" and "Mei Wang" recognized as "Famous Trademarks of Guangdong Province"[28]. - The company has received multiple honors, including being recognized as a "National Quality Credit AAA Enterprise" and a "Top 100 Private Enterprises in Guangdong Province"[29]. - The company plans to expand its market presence by leveraging its strong technical development capabilities and rich market operation experience in the gaming sector[27]. - The company achieved a revenue of 680.57 million yuan in 2020, representing a year-on-year growth of 31.52%[38]. - The revenue from the chemical raw materials and chemical products manufacturing industry was CNY 553,921,663.93, accounting for 81.39% of total revenue, with a year-on-year increase of 9.07%[45]. - The revenue from the software and information technology services industry was CNY 120,112,978.86, contributing 17.65% to total revenue[45]. Acquisitions and Investments - The company completed the acquisition of 100% equity in Hainan Huaduo Network Technology Co., Ltd. and Hangzhou Lei Yan Network Technology Co., Ltd. in August 2020, contributing positively to its performance[38]. - The company acquired 100% equity of Hainan Huaduo Network Technology Co., Ltd. and Hangzhou Lei Yan Network Technology Co., Ltd., which contributed CNY 91,632,582.42 in revenue and CNY 64,840,748.34 in net profit from Hangzhou Lei Yan, and CNY 28,480,396.44 in revenue and CNY 19,164,070.59 in net profit from Hainan Huaduo[53]. - The company has invested CNY 60 million of idle raised funds in financial products that have not yet matured[83]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 100 million RMB allocated for potential mergers and acquisitions[178]. Research and Development - Research and development expenses reached 46,269,566.37 CNY, a significant increase of 197.92% year-over-year, accounting for 6.80% of total revenue[62]. - The company reported a total of 258 R&D personnel, an increase of 145.71% from 105 in the previous year[62]. - The company holds 997 independent intellectual property trademarks, 41 invention patents, and 83 design patents, showcasing its strong R&D capabilities[32]. - The company has successfully passed the re-certification as a high-tech enterprise and obtained several invention patents related to oral care and hair care products[40]. - The company is investing 50 million RMB in R&D for new technologies aimed at enhancing product efficacy and safety[178]. Cash Dividend and Profit Distribution - The company plans to distribute a cash dividend of CNY 2.55 per 10 shares, based on a total of 122,135,745 shares[4]. - The company has a clear cash dividend policy, distributing cash dividends of RMB 1 per 10 shares in 2018, RMB 1 per 10 shares in 2019, and proposing RMB 2.55 per 10 shares for 2020, totaling RMB 31,144,614.98 for the latter[109][110]. - The total distributable profit as of December 31, 2020, was RMB 190,832,554.06, with a cash dividend distribution of RMB 31,144,614.98, accounting for 16.32% of the total profit distribution[111]. - The company's retained earnings at the beginning of the year were RMB 102,038,280.90, after deducting the cash dividends paid for the previous year[111]. - The company has maintained a good profit status and aims to meet shareholder expectations for continuous dividends while considering future growth prospects[111]. Corporate Governance and Compliance - The company changed its accounting firm to Deloitte Touche Tohmatsu Certified Public Accountants LLP for the 2020 financial audit, with the decision approved by the board on December 24, 2020[125]. - The independent directors attended all board meetings, with no objections raised against company matters during the reporting period[200][199]. - The company has implemented measures to enhance information disclosure and transparency for investors[191]. - The board of directors held 8 meetings during the reporting period, ensuring compliance with governance regulations[190]. - The company has maintained its compliance with regulations regarding shareholding and management changes[171]. Social Responsibility and Community Engagement - The company emphasizes a commitment to social responsibility, focusing on consumer needs, technological innovation, and high-quality products[145]. - The company has actively participated in social welfare and charity activities, contributing to local community development[147]. - The company has a strong focus on employee rights, providing training and promoting a healthy work environment[146]. - The company has no environmental protection issues and is not listed as a key pollutant unit by environmental authorities[149]. Future Outlook and Strategic Plans - The company provided a positive outlook for 2021, projecting a revenue growth of 10% to 12% based on market expansion strategies[178]. - New product launches are expected to contribute an additional 200 million RMB in revenue in 2021, focusing on health and personal care segments[178]. - Market expansion efforts include entering three new provinces in China, targeting a 5% market share increase in these regions by the end of 2021[178]. - The company aims for revenue and net profit growth in the 2021 fiscal year, according to its overall budget plan[97].

Financial Performance - Operating revenue for the period reached CNY 205,123,000.90, a year-on-year increase of 62.17%[7] - Net profit attributable to shareholders surged by 299.34% to CNY 30,901,757.77 for the quarter[7] - The company reported a net profit attributable to shareholders of CNY 46,897,099.26 for the year-to-date, reflecting a 125.96% increase[7] - The net profit after deducting non-recurring gains and losses for the quarter was CNY 32,059,254.66, a significant increase of 439.43%[7] - Basic earnings per share rose by 316.67% to CNY 0.25[7] - The projected net profit for the year is estimated to be between 10,000 and 13,000 million CNY, representing a significant increase of 333.34% to 463.34% compared to the previous year[27] - The basic earnings per share are expected to rise to between 0.82 and 1.06 CNY, reflecting an increase of 331.58% to 457.89% year-on-year[27] Asset and Liability Management - Total assets increased by 27.71% to CNY 893,419,335.20 compared to the end of the previous year[7] - The total assets of the company as of September 30, 2020, amounted to 893,419,335.20 CNY, an increase from 699,552,468.03 CNY at the end of 2019[38] - The company's current liabilities reached 292,830,707.03 CNY, compared to 134,117,813.31 CNY in the previous year[39] - Total liabilities increased to ¥211,446,801.77 from ¥85,127,599.38, indicating a rise in short-term borrowings and accounts payable[43] - The company reported a total owner's equity of CNY 585,979,156.94, with retained earnings of CNY 122,582,783.12[76] Cash Flow Analysis - Net cash flow from operating activities increased by 179.63% to CNY 60,037,924.18[7] - The net cash flow from operating activities improved significantly by 599.13%, reaching ¥76,662,629.14, attributed to increased cash receipts from sales and services[17] - The net cash flow from financing activities increased by 757.69% to ¥53,840,010.76, primarily due to new short-term bank loans[17] - The cash inflow from operating activities totaled CNY 504,359,298.12, compared to CNY 417,881,957.21 in the previous period, showing improved cash generation[63] - The net cash flow from investment activities was significantly negative at -¥362,482,465.76, compared to a positive cash flow of ¥45,162,732.77 in the previous period[65] Investment and Development - Research and development expenses rose by 75.44% to ¥19,441,357.35, primarily due to increased investment in new subsidiaries[17] - The company has completed 52.55% of the investment in the daily chemical production line technology transformation project, with an investment of 2,123.18 million CNY out of a total of 4,040.53 million CNY[25] - The research and development center project has achieved 78.76% of its investment goal, with 1,181.36 million CNY invested out of a total of 1,500 million CNY[25] - The company has made significant investments in long-term equity, with long-term investments rising to ¥284,920,000.00 from ¥23,610,000.00 year-on-year, suggesting strategic growth initiatives[42] Shareholder Information - The total number of shareholders at the end of the reporting period was 5,547[11] - The company has not made any adjustments or restatements to previous accounting data[7] Financial Position - The weighted average return on net assets improved to 5.29%, up from 3.90% in the previous year[7] - The company's equity attributable to shareholders increased to ¥598,693,470.15 from ¥585,979,156.94, indicating a stable financial position[43] - The company has a capital reserve of CNY 323,229,974.44 and a surplus reserve of CNY 18,030,654.38[76] Operational Efficiency - Operating profit for the quarter was ¥36,882,879.95, up from ¥8,845,435.31 in Q3 2019, reflecting improved operational efficiency[47] - The company reported a total operating cost of ¥161,638,746.68, up from ¥118,294,865.55 in Q3 2019, driven by increased sales and administrative expenses[46] - The total operating costs for the quarter were CNY 381,968,636.81, compared to CNY 339,096,775.24 in the previous year, indicating a rise in operational expenses[53] Compliance and Adjustments - The company has implemented new revenue and leasing standards, adjusting the presentation of contract liabilities and other current liabilities accordingly[76] - The third quarter report was not audited, indicating that the figures may be subject to further review[77]

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 239,272,558.62, representing a 3.22% increase compared to CNY 231,806,376.42 in the same period last year[16]. - The net profit attributable to shareholders of the listed company was CNY 15,995,341.49, an increase of 22.89% from CNY 13,015,959.26 year-on-year[16]. - The net profit after deducting non-recurring gains and losses was CNY 11,007,183.10, up 17.37% from CNY 9,378,267.09 in the previous year[16]. - The net cash flow from operating activities was CNY 16,624,704.96, a significant improvement of 129.20% compared to a negative cash flow of CNY -56,943,616.22 in the same period last year[16]. - Basic earnings per share increased to CNY 0.13, up 18.18% from CNY 0.11 in the previous year[16]. - Operating profit rose by 21.84% compared to the same period last year, driven by increased demand for personal protective products due to the pandemic[38]. - The total profit for the first half of 2020 was CNY 17,949,156.77, compared to CNY 14,382,075.88 in the first half of 2019, reflecting a growth of 24.5%[138]. - The company reported a net loss of approximately 12,213,574.50 CNY during the first half of 2020, indicating a significant decline in profitability[160]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 725,713,278.06, reflecting a 3.74% increase from CNY 699,552,468.03 at the end of the previous year[16]. - The total liabilities rose to ¥156,496,856.35 from ¥134,117,813.31, indicating an increase of about 16.7%[130]. - The company's cash and cash equivalents decreased to ¥155,508,736.42 from ¥321,492,211.82, a decline of about 51.6%[128]. - The total owner's equity as of June 30, 2020, was ¥569,216,421.71, slightly up from ¥565,434,654.72, showing a growth of about 0.5%[131]. Revenue Sources and Market Strategy - The revenue from the distribution model accounts for over 95% of the total operating income, with a retail network covering approximately 37,000 outlets nationwide[27]. - The company aims to create a national brand and provide high-quality consumer experiences with a commitment to safety, health, and natural ingredients[24]. - The company has focused on expanding its sales channels, including partnerships with major supermarkets like Walmart and regional chains[27]. - The company aims to capture market opportunities in both tier-one and tier-two cities, enhancing its competitive edge in the health care product sector[31]. Research and Development - The company established a comprehensive R&D system and has been recognized as a "High-tech Enterprise" with national laboratory accreditation[34]. - Research and development expenses increased by 17.00% to CNY 8,600,947.42 from CNY 7,351,115.14 in the previous year[42]. - The company actively participated in the formulation and revision of 14 national and industry standards, enhancing its leadership in the domestic daily chemical industry[35]. Marketing and Brand Presence - The company has a robust marketing strategy, leveraging popular media to enhance brand visibility and consumer engagement, particularly for its flagship products[31]. - The company has established a strong brand presence with key brands such as "Ti Hua Zhi Xiu" and "Mei Wang," which are recognized as "Famous Trademarks of Guangdong Province"[28]. - The company has successfully expanded its product offerings, including the new "Ying Kou" brand featuring caviar as a key ingredient, aimed at high-end market development[25]. Financial Management and Investments - The company has cumulatively invested CNY 9,462.93 million of the raised funds, with no changes in the use of raised funds reported during the period[54][57]. - The company plans to utilize the raised funds according to the investment plan and actual production needs, ensuring efficient use of resources[61]. - The company reported a significant decrease in cash flow from investing activities, which was CNY -170,390,300.85, down 271.22% from CNY 99,513,276.78 in the previous year[42]. Corporate Governance and Compliance - The financial report for the half-year period has not been audited[81]. - The company has not faced any major litigation or arbitration matters during the reporting period[83]. - The company has no significant related party transactions during the reporting period[86]. - The company adheres to the accounting standards issued by the Ministry of Finance and the China Securities Regulatory Commission for financial reporting[165]. Social Responsibility - The company engaged in social responsibility initiatives, including a total of 2 million RMB for educational support for impoverished students[100]. - The company donated a batch of protective products to aid over 100 primary and secondary schools during the pandemic[39].

Financial Performance - The company's revenue for Q1 2020 was ¥92,005,273.17, representing a decrease of 17.23% compared to ¥111,161,911.79 in the same period last year[7] - Net profit attributable to shareholders was ¥6,040,118.93, down 29.50% from ¥8,568,054.69 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥3,536,279.25, a decline of 49.80% compared to ¥7,044,243.52 in the previous year[7] - Basic and diluted earnings per share were both ¥0.05, down 28.57% from ¥0.07 in the previous year[7] - Total operating revenue for Q1 2020 was CNY 92,005,273.17, a decrease from CNY 111,161,911.79 in the previous period[36] - Net profit for Q1 2020 was CNY 6,040,118.93, compared to CNY 8,568,054.69 in the same period last year, representing a decline of approximately 29.5%[38] - The company's operating revenue for the current period is CNY 69,438,334.20, a decrease from CNY 91,944,181.68 in the previous period[41] - The net profit for the current period is a loss of CNY 892,044.98, compared to a profit of CNY 10,132,717.10 in the previous period[42] - The total comprehensive income for the current period is CNY -892,044.98, compared to CNY 10,132,717.10 in the previous period[43] Cash Flow and Liquidity - The net cash flow from operating activities improved by 30.01%, amounting to -¥48,653,019.41, compared to -¥69,511,979.59 in the same period last year[7] - Operating cash flow improved by 30.01%, with a net cash outflow of ¥48,653,019.41 compared to ¥69,511,979.59 in the previous year[15] - The cash flow from operating activities shows a net outflow of CNY 48,653,019.41, compared to a net outflow of CNY 69,511,979.59 in the previous period[46] - The net cash flow from operating activities was -46,417,337.84 yuan, compared to -69,179,070.58 yuan in the previous period, indicating an improvement of approximately 33%[49] - The net increase in cash and cash equivalents for the period was -206,069,370.11 yuan, compared to -19,818,192.65 yuan in the previous period, reflecting a significant decline[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥674,888,759.54, a decrease of 3.53% from ¥699,552,468.03 at the end of the previous year[7] - Total assets as of March 31, 2020, were CNY 640,712,377.00, down from CNY 671,106,756.32 at the end of 2019[34] - Current assets decreased to CNY 544,519,285.09 from CNY 572,090,185.87 at the end of 2019, reflecting a decline of about 4.8%[33] - Total liabilities decreased to CNY 55,625,265.04 from CNY 85,127,599.38, a reduction of approximately 34.6%[34] - Total assets decreased to ¥674,888,759.54 from ¥699,552,468.03, reflecting a decline in both current and non-current assets[15] Shareholder Information - The company reported a total of 10,009 common shareholders at the end of the reporting period[11] - The largest shareholder, Chen Qinfang, holds 49.34% of the shares, amounting to 60,258,000 shares, with 23,250,000 shares pledged[11] - The net assets attributable to shareholders increased by 1.06% to ¥571,426,267.02 from ¥565,434,654.72 at the end of the previous year[7] Government Support and Subsidies - The company received government subsidies amounting to ¥200,000 during the reporting period[8] - Other income increased by 100% to ¥200,000.00, attributed to government subsidies received during the period[15] Changes in Financial Position - Cash and cash equivalents decreased by 64.79% to ¥113,187,160.14 from ¥321,492,211.82 due to the purchase of financial products during the reporting period[15] - Trading financial assets increased by 156.80% to ¥263,940,709.59 from ¥102,779,726.03, primarily due to the addition of new financial products[15] - Accounts receivable rose by 51.18% to ¥28,842,972.62 from ¥19,078,453.24, influenced by extended credit terms for some customers due to the pandemic[15] - Investment cash flow turned negative at ¥-159,652,032.27, a decrease of 423.44% from a positive cash flow of ¥49,360,877.93, mainly due to the purchase of financial products[15] Operational Costs and Expenses - Total operating costs for Q1 2020 were CNY 86,477,657.11, down from CNY 102,232,144.81 in the previous period[37] - The company incurred research and development expenses of CNY 3,430,705.20, slightly down from CNY 3,612,961.52 in the previous period[41] - The cash paid for purchasing goods and services was 87,758,526.63 yuan, down from 115,108,079.78 yuan in the previous period, indicating a reduction in operational costs[49] Audit and Reporting Standards - The company has not yet audited the first quarter report, which may affect the reliability of the financial data presented[58] - The company has adopted new revenue and lease standards starting in 2020, which may impact future financial reporting and comparisons[57]

Financial Performance - The company's operating revenue for 2019 was CNY 517,463,183.51, a decrease of 5.27% compared to CNY 546,276,524.35 in 2018[16] - The net profit attributable to shareholders for 2019 was CNY 23,076,746.81, down 22.20% from CNY 29,660,736.75 in the previous year[16] - Basic earnings per share for 2019 were CNY 0.19, a decrease of 20.83% from CNY 0.24 in 2018[16] - The company reported a total revenue of 7,126,958.07 in 2019, a decrease from 9,934,643.41 in 2018, reflecting a decline of approximately 28.5%[23] - The revenue from daily chemical products was 505,501.48 million yuan, accounting for 97.69% of total revenue, with a year-on-year decrease of 5.24%[45] - The net profit attributable to shareholders was 2,307.67 million yuan, reflecting a decline attributed to reduced operating revenue and increased inventory impairment provisions[41] - The company achieved operating revenue of 51,746.32 million yuan, a decrease of 5.27% compared to the previous year, primarily due to intensified competition in the daily chemical market and adjustments in distribution channels[41] Cash Flow and Investments - The net cash flow from operating activities increased significantly to CNY 39,845,342.00, a rise of 1,148.41% compared to CNY 3,191,684.43 in 2018[16] - Operating cash inflow totaled ¥621,575,543.75, reflecting a year-on-year increase of 2.17%[59] - Investment cash inflow increased by 78.28% to ¥686,160,887.08, attributed to the purchase and redemption of financial products during the reporting period[60] - The company's cash and cash equivalents increased by ¥190,362,502.44, marking a 165.09% rise compared to the previous year[60] - The company has invested RMB 3.98 million to replace self-raised funds for projects approved by the board[71] - The total amount of raised funds was RMB 255.72 million, with a net amount of RMB 216.91 million after deducting related expenses[70] Assets and Liabilities - Total assets at the end of 2019 were CNY 699,552,468.03, reflecting a slight increase of 0.13% from CNY 698,664,409.44 at the end of 2018[17] - The total amount of raised funds used in the current period was RMB 27.77 million, with a cumulative usage of RMB 88.80 million[70] - The company’s total liabilities and equity remained consistent with previous reporting periods, indicating stable financial health[102] - Total liabilities were CNY 147,768,474.11, unchanged from the previous year[115] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1 per 10 shares, based on a total of 122,135,745 shares[4] - The cash dividend for 2019 represents 52.93% of the net profit attributable to the company's ordinary shareholders[95] - The cash dividend distribution plan for 2019 is set at RMB 1 per 10 shares, totaling RMB 12,213,574.50, which represents 100% of the profit distribution[96] - The total cash dividend distributed to shareholders was RMB 8,142,383, with a cash dividend of RMB 1 per 10 shares[151] Research and Development - The company has developed a comprehensive R&D system and holds 995 independent intellectual property trademarks, 39 invention patents, 74 design patents, and 50 copyrights[36] - Research and development expenses amounted to ¥15,530,763.08, which is 3.64% of the company's operating revenue[56] - The company established a new R&D branch in Guangzhou, enhancing its innovation capabilities through strategic partnerships with higher education institutions[40] Market and Product Strategy - The company’s main business includes the production and sale of health care products, with a focus on high-quality consumer experiences[26] - The company launched a new product line "盈蔻," featuring imported caviar as a key ingredient, aimed at the high-end market segment[27] - The company aims to leverage the growth of domestic brands and is actively upgrading its products to align with market opportunities[35] - The company plans to enhance brand building and upgrade its products to cater to younger consumers, focusing on home and disinfectant products as new growth points[83] Governance and Compliance - The company held five board meetings during the reporting period, reviewing 29 proposals to enhance governance and operational efficiency[40] - The company has appointed Guangdong Zhengzhong Zhujiang Accounting Firm as its auditor, with an audit fee of 720,000 RMB and a continuous service period of 5 years[120] - The company ensures transparency in information disclosure, complying with relevant laws and regulations[189] Shareholder Structure - The total number of ordinary shareholders at the end of the reporting period was 14,040, compared to 10,009 at the end of the previous month, indicating a significant increase[158] - The largest shareholder, Chen Qinfang, holds 49.34% of the shares, with a total of 60,258,000 shares, reflecting an increase of 20,086,000 shares during the reporting period[158] - The company has 10 major shareholders, with no reported related party transactions among them, except for Chen Qinfang and Chen Mufa, who are brothers[158] Employee and Management Structure - The total number of employees in the company is 1,358, with 879 in the parent company and 479 in major subsidiaries[182] - The total remuneration for directors, supervisors, and senior management during the reporting period amounts to 2.89 million yuan[182] - The company emphasizes a salary system that aligns with its development stage and considers various factors such as industry conditions and employee capabilities[183] Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in its future development plans[4] - The company is focused on maintaining brand integrity and addressing risks related to brand image and distribution models[87]

Financial Performance - Operating revenue for the reporting period was CNY 126,485,288.71, an increase of 10.09% year-on-year [7]. - Net profit attributable to shareholders was CNY 7,738,253.15, representing a growth of 28.44% compared to the same period last year [7]. - Basic earnings per share were CNY 0.06, up by 20.00% year-on-year [7]. - The weighted average return on net assets was 1.38%, an increase of 0.27% compared to the previous year [7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 5,943,223.86, a substantial increase of 65.38% [7]. - The company reported a net profit of CNY 20,754,212.41 for the year-to-date, a decrease of 18.58% compared to the same period last year [7]. - Total operating revenue for Q3 2019 was CNY 126,485,288.71, an increase of 10.4% compared to CNY 114,890,419.33 in the same period last year [35]. - Net profit for Q3 2019 reached CNY 7,738,253.15, representing a 28.5% increase from CNY 6,024,605.81 in Q3 2018 [36]. - The total comprehensive income for Q3 2019 was CNY 7,738,253.15, an increase from CNY 6,024,605.81 in Q3 2018 [39]. - The total profit for Q3 2019 was CNY 13,299,653.34, a decrease from CNY 15,721,580.16 in Q3 2018 [39]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 695,329,104.10, a decrease of 0.48% compared to the end of the previous year [7]. - Total assets decreased slightly to ¥695,329,104.10 from ¥698,664,409.44 [26]. - Total liabilities decreased to ¥131,821,339.36 from ¥147,668,474.11 [27]. - The company's total assets as of September 30, 2019, were CNY 661,350,458.19, slightly down from CNY 663,596,240.52 at the end of 2018 [33]. - Current assets totaled CNY 564,925,414.57, a decrease from CNY 572,227,250.73 at the end of 2018 [31]. - The total equity attributable to shareholders of the parent company was CNY 583,740,495.22, up from CNY 556,885,509.66 [33]. - The company's total equity amounted to 550,895,935.33 CNY, remaining stable compared to the previous period [62]. Cash Flow - Net cash flow from operating activities reached CNY 41,584,255.00, a significant increase of 142.80% [7]. - Cash flow from operating activities improved by 64.34% to -¥15,359,361.22, attributed to increased cash received from sales [15]. - Investment activities generated a net cash flow of ¥45,294,987.95, a 122.25% increase due to the recovery of investments [15]. - Cash flow from operating activities showed a net outflow of CNY 15,359,361.22, an improvement from a net outflow of CNY 43,067,577.85 in the previous period [51]. - The company reported a decrease in cash outflow from financing activities to 8,186,279.05 CNY from 17,988,500.32 CNY in the previous period [57]. - The net increase in cash and cash equivalents for the period was 15,353,168.63 CNY, a recovery from a decrease of 260,609,693.96 CNY in the prior period [57]. Shareholder Information - The total number of shareholders at the end of the reporting period was 12,914 [11]. - The largest shareholder, Chen Qinfang, holds 49.34% of the shares, amounting to 60,258,000 shares, with 23,250,000 shares pledged [11]. Expenses - Total operating costs for Q3 2019 were CNY 118,294,865.55, up from CNY 110,976,223.99, reflecting a growth of 6.0% [35]. - The total operating costs for the year-to-date period were CNY 339,096,775.24, down from CNY 351,810,293.42 in the previous year [42]. - Research and development expenses for Q3 2019 were CNY 3,730,484.23, slightly up from CNY 3,719,687.04 in the previous year [35]. - Research and development expenses increased to CNY 11,081,599.37, up from CNY 10,046,960.37, indicating a growth of 10.3% [48]. - The company reported a decrease in sales expenses to CNY 11,343,129.23 from CNY 15,142,999.47, a reduction of approximately 25.5% [47]. Other Financial Metrics - The company reported a significant decrease of 84.79% in other income to ¥220,625.00 due to reduced government subsidies [15]. - The company’s capital stock increased by 50.00% to ¥122,135,745.00 due to the conversion of capital reserves into share capital [15]. - The company has no overdue commitments from controlling shareholders or related parties during the reporting period [16]. - The company received 390,000,000.00 CNY from investment recoveries, significantly higher than 210,000,000.00 CNY in the last period [56]. - The company reported an investment income of CNY 2,103,726.04 for Q3 2019, compared to CNY 2,377,621.31 in the same period last year [39].

Financial Performance - The company's operating revenue for the first half of 2019 was ¥231,806,376.42, a decrease of 10.72% compared to ¥259,641,786.74 in the same period last year[16]. - The net profit attributable to shareholders for the first half of 2019 was ¥13,015,959.26, down 33.13% from ¥19,465,072.60 in the previous year[16]. - The net profit after deducting non-recurring gains and losses was ¥9,378,267.09, a decrease of 31.45% compared to ¥13,680,772.48 in the same period last year[16]. - The basic earnings per share for the first half of 2019 was ¥0.11, down 31.25% from ¥0.16 in the previous year[16]. - Operating profit for the period was RMB 14.31 million, with a total profit of RMB 14.38 million, and net profit attributable to shareholders was RMB 13.02 million, all showing a decline compared to the previous year[40]. - Total operating revenue for the first half of 2019 was CNY 231.81 million, a decrease of 10.73% from CNY 259.64 million in the same period of 2018[139]. - Net profit for the first half of 2019 was CNY 13.02 million, representing a decline of 33.36% compared to CNY 19.47 million in the first half of 2018[140]. - Total profit for the first half of 2019 was CNY 14.38 million, down 37.51% from CNY 23.05 million in the first half of 2018[140]. Assets and Liabilities - The total assets at the end of the reporting period were ¥658,638,210.69, a decrease of 5.73% from ¥698,664,409.44 at the end of the previous year[16]. - The total liabilities decreased from CNY 147,768,474.11 to CNY 102,868,699.10, a decline of about 30.4%[132]. - Current assets decreased from CNY 620,180,344.24 to CNY 575,883,527.86, a reduction of about 7.1%[130]. - The company's total non-current assets increased from CNY 78,484,065.20 to CNY 82,754,682.83, an increase of about 5.3%[130]. - Cash and cash equivalents at the end of the reporting period amounted to RMB 165.77 million, an increase in proportion to total assets from 15.30% to 25.17%[49]. Cash Flow - The net cash flow from operating activities was -¥56,943,616.22, an improvement of 5.40% compared to -¥60,194,322.60 in the same period last year[16]. - The company reported a total cash inflow from operating activities of 250,818,265.73 CNY in the first half of 2019, slightly up from 249,572,331.14 CNY in the first half of 2018[149]. - The net cash flow from investment activities was 99,513,276.78 CNY for the first half of 2019, a substantial improvement from -244,677,108.40 CNY in the same period of the previous year[149]. - The total cash outflow from financing activities was 8,186,279.05 CNY in the first half of 2019, a decrease from 17,988,500.32 CNY in the same period of 2018, showing improved cash management[150]. Market and Brand Strategy - The company continues to focus on the health care product sector, emphasizing consumer demand and technological innovation[24]. - The company's main brands include "Ti Hua Zhi Xiu," "Mei Wang," and "Chu Cui," focusing on high-cost performance products for hair, skin, oral, and home care[25]. - Over 95% of the company's revenue comes from the distribution model, successfully establishing a network of over 30,000 retail outlets nationwide, including major chains like Walmart and China Resources Vanguard[29]. - The company has been recognized as a "Guangdong Province Famous Trademark" for its brands "Ti Hua Zhi Xiu" and "Mei Wang," highlighting its strong brand development strategy[30]. - The company has expanded its marketing network, increasing retail outlets by nearly 1,000 compared to the end of 2018, capitalizing on the growth of domestic brands[35]. Research and Development - Research and development investment increased by 16.18% to RMB 7.35 million, reflecting the company's commitment to innovation despite revenue challenges[43]. - The company holds 908 trademarks, 37 invention patents, 72 design patents, and 50 copyrights, showcasing its strong intellectual property portfolio[36]. - The company has established high-level R&D platforms, including the "Guangdong Provincial Bioengineering Technology Research Center" and "Guangdong Provincial Enterprise Technology Center"[36]. Corporate Governance and Compliance - The company has not engaged in any major non-raised fund investment projects during the reporting period[66]. - The company has not experienced any major litigation or arbitration matters during the reporting period[81]. - The company has not engaged in any significant related party transactions during the reporting period[84]. - The company has a strong commitment to investor rights protection, ensuring timely and accurate information disclosure through multiple channels[97]. Future Outlook - The company aims to expand into new markets and customer bases while consolidating its presence in mature markets to drive future growth[40]. - The company aims to enhance its market presence through potential new product developments and strategic expansions[167]. - The company plans to utilize raised funds for production line technology upgrades, marketing network construction, and R&D center establishment[72].